Thursday, December 2, 2021

Laurus Labs

Utilise services of district hospital: Karimnagar Collector

Karimnagar: District Collector RV Karnan advised the people on Tuesday to utilise the medical and other facilities provided in the district headquarters government hospital. The...

Flow Chemistry Centre of Excellence coming up in Hyderabad

Hyderabad: Continuing its efforts to support the pharma and life sciences segments, Government of Telangana State together with pharma industry players announced a new...

Hyderabad-based Laurus Labs to acquire minority stake in ImmunoACT

Hyderabad: Laurus Labs has signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company to acquire...

Laurus Labs partners with Unitaid, Clinton Health Access Initiative to develop pediatric HIV drug

Hyderabad: Hyderabad-based Laurus Labs, Unitaid and the Clinton Health Access Initiative (CHAI) have partnered to accelerate the development, commercialisation, and registration of the second-...

Hyderabad-based Laurus Labs receives licence to manufacture 2DG

2DG has been given emergency approval by the Drug Controller General of India (DCGI) for the treatment of Covid-19 patients in the country.

Laurus Labs registers multi-fold growth

Hyderabad-based company’s revenues for FY21 stood at Rs 4,814 crore, up 70 per cent Y-o-Y while its profit jumped 286 per cent to Rs 984 crore Y-o-Y

Laurus Labs wins Golden Peacock Award

Instituted in 1991 by the Institute of Directors (IOD), India, the Golden Peacock Award is regarded as a global recognition for corporate excellence.

Laurus Labs posts net profit at Rs 273 crore

The company’s revenue grew by 76 per cent at Rs 1,288 crore as against Rs 730 crore in the year-ago period.

Laurus to acquire majority stake in Richcore

Hyderabad-based company to acquire 72.55% stake in Bengaluru biotech firm for over Rs 246 crore

Laurus Labs Q2 net profit up 325% year-on-year

The company’s revenue for the first half of the fiscal went up to Rs 2,113 crore, up 67 per cent Y-o-Y, while net profit jumped 475 per cent to Rs 414 crore Y-o-Y.

80 per cent investment proposals operationalised: KTR

Minister said the State government was attracting investments even during the Covid-19 pandemic due to its continuous efforts over a period of time

Hyderabad attracts Rs 700 crore investments in pharma

Granules India, Laurus Labs to set up new manufacturing facilities for finished dosages and formulations, respectively

Latest News

- Advertisement -